ACADIA Pharmaceuticals Inc.ACADNASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank86
3Y CAGR-3.1%
5Y CAGR+0.6%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-3.1%/yr
vs +17.9%/yr prior
5Y CAGR
+0.6%/yr
Recent deceleration
Acceleration
-21.0pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$328.80M+8.4%
2024$303.25M-13.8%
2023$351.62M-2.8%
2022$361.57M+51.0%
2021$239.41M-25.0%
2020$319.13M+32.8%
2019$240.38M+28.4%
2018$187.16M+25.5%
2017$149.19M+50.3%
2016$99.28M-